BlackRock Fund Advisors’s ProPhase Labs PRPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PRPH
VIP
BlackRock Fund Advisors's PRPH Position: Q4 2016 in Review
BlackRock Fund Advisors increased its ProPhase Labs (PRPH) stake by 28% in Q4 2016, buying an estimated $2.18K and bringing the position to 491 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #3967.
BlackRock Fund Advisors first reported a position in PRPH in Q4 2015 and has held it in 5 quarters since. 13 funds tracked by Wall St. Rank hold PRPH as of Q4 2016.
- BlackRock Fund Advisors held 491 shares of ProPhase Labs worth $10K as of Q4 2016.
- BlackRock Fund Advisors bought 108 ProPhase Labs shares in Q4 2016, an estimated $2.18K.
- ProPhase Labs made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3967 holding.
- BlackRock Fund Advisors first reported a position in ProPhase Labs in Q4 2015 and has held it in 5 quarters since.
- 13 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.